⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BHVN News
Biohaven Ltd.
Biohaven Announces Pricing of $175 Million Public Offering of Common Shares
prnewswire.com
BHVN
Biohaven Announces Proposed Public Offering of Common Shares
prnewswire.com
BHVN
Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments
prnewswire.com
BHVN
FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia
prnewswire.com
BHVN
Biohaven Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 12, 2025 to Discuss Your Rights - BHVN
prnewswire.com
BHVN
BHVN Deadline: BHVN Investors Have Opportunity to Lead Biohaven Ltd. Securities Fraud Lawsuit
prnewswire.com
BHVN
Deadline Soon: Biohaven Ltd. (BHVN) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
businesswire.com
BHVN
Shareholders that lost money on Biohaven Ltd.(BHVN) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
prnewswire.com
BHVN
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven
businesswire.com
BHVN
Levi & Korsinsky Reminds Biohaven Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 12, 2025 - BHVN
prnewswire.com
BHVN